Motion DNATV Show Opens to Light Arizona Viewing Audience, But Show Looks Promising

Motion DNATV Show Opens to Light Arizona Viewing Audience, But Show Looks Promising

SCOTTSDALE, Ariz., Nov. 2 /PRNewswire-FirstCall/ -- Motion DNA Corporation (Pink Sheets: MTDX) is pleased to announce it has completed and aired the first episode of the Motion DNA television show.

"The overnight ratings were actually pretty good for the first show with zero advertising to promote it ahead of time," said Zig Ziegler, President and CEO of Motion DNA. "We are expecting our viewing audience to grow immensely over the next few weeks as we increase our marketing efforts."

According to the Nielsen Ratings released by KAZ-TV, Motion DNA: Blending Sports, Fitness and Science scored a .3 rating for the second half of the 30 minute broadcast which featured the analysis of a high school athlete's running mechanics. The average rating for the show was .1, which suggests approximately 7-10,000 viewers. Company officials estimate this same rating on a national broadcast would have garnered close to 400,000 viewers.

According to Emmy award-winning producer, Dan Cernia of CAI Televisions and Associates, "This is a good start for a show of this type on local television. The ratings for the second half of the show suggests that viewers tuned in late and saw enough to stick around through the end."

The initial broadcast showed real-time demonstrations of the company's BioCap and BioTrainer software. In addition to the high school athlete's running analysis, Ziegler and his staff analyzed the biomechanics of a collegiate basketball player. Viewers saw a 3D-animation and analysis by Ziegler, which included identifying physical limitations in the athletes body that caused him to miss many of his free throws and jump shots to the left.

"I believe, if used properly, we could eliminate or reduce Shaquille O'Neal's free throw shooting problems in the same amount of time that we identified and improved the athlete on the show," Ziegler added.

Copies of the opening broadcast and future shows will be rebroadcast throughout the year and also made available to members of the company's new website set to launch this weekend, www.motiondnatv.com

This press release is available on the Motion DNA Corp. IR HUB for investor commentary, feedback and questions. Investors are asked to visit http://www.agoracom.com/IR/MotionDNA . Alternatively, investors are asked to e-mail all questions and correspondence to MTDX@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and correspondence directly.

About Motion DNA:

Motion DNA Corporation provides diagnostic testing for medical professionals and sports organizations. Motion DNA's biomechanical analyses and detailed reports provide its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing preexisting injuries related to biomechanics, and improving physical performance levels. The company's technology will be available for sale beginning in December of 2005. For additional information on the company, please visit the company website at www.motiondnacorp.com.

Forward-Looking Statements:

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.

CONTACT INFORMATION

Corporate Inquiries
Curt Blakeney, Director of Public Relations
Telephone: 480-425-7734
Email: info@motiondnacorp.com

Investor Relations
AGORA Investor Relations
http://www.agoracom.com/IR/MotionDNAMTDX@Agoracom.com

Source: Motion DNA Corporation

CONTACT: Corporate Inquiries, Curt Blakeney, Director of Public
Relations of Motion DNA Corporation, +1-480-425-7734, info@motiondnacorp.com;
or Investor Relations, AGORA Investor Relations, MTDX@Agoracom.com, for Motion
DNA Corporation

Web site: http://www.agoracom.com/IR/MotionDNA

Web site: http://www.motiondnacorp.com/

-------
Profile: intent